Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Bertolini, Francesco"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Barosi G; General Medicine 2 - Center for the Study of Myelofibrosis. Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy., Campanelli R; General Medicine 2 - Center for the Study of Myelofibrosis. Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy., Massa M; General Medicine 2 - Center for Systemic Amyloidosis and High-Complexity Diseases. Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo Foundation, Pavia, Italy., Catarsi P; General Medicine 2 - Center for the Study of Myelofibrosis. Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy., Carolei A; General Medicine 2 - Center for the Study of Myelofibrosis. Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy., Abbà C; General Medicine 2 - Center for the Study of Myelofibrosis. Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy., Villani L; General Medicine 2 - Center for the Study of Myelofibrosis. Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy., Magrini U; General Medicine 2 - Center for the Study of Myelofibrosis. Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy., Gregato G; Laboratory of Hematology-Oncology, European Institute of Oncology IRCCS, Milan, Italy., Bertolini F; Laboratory of Hematology-Oncology, European Institute of Oncology IRCCS, Milan, Italy., de Silvestri A; Biometry & Clinical Epidemiology, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo Foundation, Pavia, Italy., Gale RP; Centre for Haematology Research, Department of Immunology and Inflammation, Imperial College London, London, UK., Rosti V; General Medicine 2 - Center for the Study of Myelofibrosis. Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy.
Publikováno v:
Acta haematologica [Acta Haematol] 2023; Vol. 146 (1), pp. 14-25. Date of Electronic Publication: 2022 Nov 07.
Autor:
Barosi G; Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy., Rosti V; Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy., Massa M; Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo Foundation, Pavia, Italy., Campanelli R; Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy., Villani L; Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy., Catarsi P; Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy., Carolei A; Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy., Abbà C; Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy., Lodigiani C; IRCCS Humanitas Clinical and Research Center, Rozzano, Italy., Primignani M; Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, CRC 'A. M. and A. Migliavacca' Center for Liver Disease, Milan, Italy., Gregato G; Laboratory of Hematology-Oncology, European Institute of Oncology IRCCS, Milan, Italy., Bertolini F; Laboratory of Hematology-Oncology, European Institute of Oncology IRCCS, Milan, Italy., Magrini U; Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy., Gale RP; Department of Immunology and Inflammation, Center for Haematology Research, Imperial College London, London, United Kingdom.
Publikováno v:
Acta haematologica [Acta Haematol] 2022; Vol. 145 (1), pp. 30-37. Date of Electronic Publication: 2021 Jul 19.
Autor:
Mancuso P; Hematology-Oncology, European Institute of Oncology, Milan, Italy., Rabascio C, Bertolini F
Publikováno v:
Pathophysiology of haemostasis and thrombosis [Pathophysiol Haemost Thromb] 2003 Sep-2004 Dec; Vol. 33 (5-6), pp. 503-6.